LobbyingAstct lobbying by quarter
Astct's latest lobbying report covers Q2 2026, at $70K. The four quarters Q4 2025–Q3 2026 total $210K. Its first report covers Q1 2020; the issues it reports most are Health Issues and Medical/Disease Research/Clinical Labs.
Astct
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $210K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q1 2020
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2020 | $50K | 1 |
| Q2 2020 | $50K | 1 |
| Q3 2020 | $0 | 0 |
| Q4 2020 | $0 | 0 |
| Q1 2021 | $0 | 0 |
| Q2 2021 | $0 | 0 |
| Q3 2021 | $0 | 0 |
| Q4 2021 | $0 | 0 |
| Q1 2022 | $0 | 0 |
| Q2 2022 | $0 | 0 |
| Q3 2022 | $0 | 0 |
| Q4 2022 | $50K | 1 |
| Q1 2023 | $50K | 1 |
| Q2 2023 | $50K | 1 |
| Q3 2023 | $50K | 1 |
| Q4 2023 | $50K | 1 |
| Q1 2024 | $70K | 1 |
| Q2 2024 | $70K | 1 |
| Q3 2024 | $70K | 1 |
| Q4 2024 | $70K | 1 |
| Q1 2025 | $70K | 1 |
| Q2 2025 | $70K | 1 |
| Q3 2025 | $70K | 1 |
| Q4 2025 | $70K | 1 |
| Q1 2026 | $70K | 1 |
| Q2 2026 | $70K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$350K · 17 reports
- Medical research and clinical labs$350K · 17 reports
- Medicare and Medicaid$350K · 17 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Centers For Medicare and Medicaid Services (CMS)17 reports
- HOUSE OF REPRESENTATIVES17 reports
- SENATE17 reports
- Centers For Disease Control & Prevention (CDC)15 reports
- Food & Drug Administration (FDA)14 reports
- Health & Human Services, Dept of (HHS)10 reports
- Natl Institutes of Health (NIH)8 reports
Firms it paid
| Firm | ||
|---|---|---|
| Smithbucklin | $1.1M | 17 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/17for Q2 | Smithbucklin | $70K |
| 04/20for Q1 | Smithbucklin | $70K |
| 01/20for Q4 2025 | Smithbucklin | $70K |
| 25/10/20for Q3 2025 | Smithbucklin | $70K |
| 25/07/21for Q2 2025 | Smithbucklin | $70K |
| 25/04/21for Q1 2025 | Smithbucklin | $70K |
| 25/01/17for Q4 2024 | Smithbucklin | $70K |
| 24/10/18for Q3 2024 | Smithbucklin | $70K |
| 24/07/19for Q2 2024 | Smithbucklin | $70K |
| 24/04/22for Q1 2024 | Smithbucklin | $70K |
| 24/01/19for Q4 2023 | Smithbucklin | $50K |
| 23/11/30for Q2 2020 | Smithbucklin | $50K |
| 23/11/30for Q1 2020 | Smithbucklin | $50K |
| 23/10/20for Q3 2023 | Smithbucklin | $50K |
| 23/07/19for Q2 2023 | Smithbucklin | $50K |
| 23/04/20for Q1 2023 | Smithbucklin | $50K |
| 23/01/20for Q4 2022 | Smithbucklin | $50K |